Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016, Article ID 2530105, 10 pages
http://dx.doi.org/10.1155/2016/2530105
Research Article

Rannasangpei Is a Therapeutic Agent in the Treatment of Vascular Dementia

1Southern Medical University, Guangzhou 510515, China
2Beijing Tibetan Hospital, China Tibetology Research Center, Beijing 100029, China
3Beijing Mentougou Hospital of Traditional Chinese Medicine, Beijing 102300, China

Received 7 November 2015; Accepted 2 March 2016

Academic Editor: Ching-Liang Hsieh

Copyright © 2016 Peng Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. L. Sudduth, D. K. Powell, C. D. Smith, A. Greenstein, and D. M. Wilcock, “Induction of hyperhomocysteinemia models vascular dementia by induction of cerebral microhemorrhages and neuroinflammation,” Journal of Cerebral Blood Flow and Metabolism, vol. 33, no. 5, pp. 708–715, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. A. R. Ramos, S. I. Dib, and C. B. Wright, “Vascular dementia,” Current Translational Geriatrics and Experimental Gerontology Reports, vol. 2, no. 3, pp. 188–195, 2013. View at Publisher · View at Google Scholar
  3. J. Yuan, Z. Zhang, H. Wen et al., “Incidence of dementia and subtypes: a cohort study in four regions in China,” Alzheimer's and Dementia, vol. 12, no. 3, pp. 262–271, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. R. N. Kalaria, G. E. Maestre, R. Arizaga et al., “Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors,” The Lancet Neurology, vol. 7, no. 9, pp. 812–826, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. G. C. Román, T. Erkinjuntti, A. Wallin, L. Pantoni, and H. C. Chui, “Subcortical ischaemic vascular dementia,” Lancet Neurology, vol. 1, no. 7, pp. 426–436, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Liu and J. Zhang, “Cerebral hypoperfusion and cognitive impairment: the pathogenic role of vascular oxidative stress,” International Journal of Neuroscience, vol. 122, no. 9, pp. 494–499, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Xi, M. Wang, W. Zhang et al., “Neuronal damage, central cholinergic dysfunction and oxidative damage correlate with cognitive deficits in rats with chronic cerebral hypoperfusion,” Neurobiology of Learning and Memory, vol. 109, pp. 7–19, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Deiana, B. Platt, and G. Riedel, “The cholinergic system and spatial learning,” Behavioural Brain Research, vol. 221, no. 2, pp. 389–411, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Toyama, N. Koibuchi, K. Uekawa et al., “Apoptosis signal-regulating kinase 1 is a novel target molecule for cognitive impairment induced by chronic cerebral hypoperfusion,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 34, no. 3, pp. 616–625, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. K. P. Reuter, T. E. Weißhuhn, and C. M. Witt, “Tibetan medicine: a systematic review of the clinical research available in the west,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 213407, 16 pages, 2013. View at Publisher · View at Google Scholar
  11. M.-C. Wan, J.-S. Lou, and Y.-W. Qin, “Application of Rannasangpei in the treatment of cardiovascular and cerebrovascular diseases,” Pharmaceutical Care and Research, vol. 9, no. 4, pp. 283–285, 2009. View at Google Scholar
  12. A. Zhu, “P2-376: effect of tibet medicine in patients with Alzheimer's disease at high altitude,” Alzheimer's & Dementia, vol. 4, no. 4, p. T483, 2008. View at Publisher · View at Google Scholar
  13. B. Clark, The Quintessence Tantras of Tibetan Medicine, Shambhala Publications, 2014.
  14. T. Dakpa, “Unique aspect of tibetan medicine,” Acupuncture and Electro-Therapeutics Research, vol. 39, no. 1, pp. 27–43, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. X. Y. Zhao, M. Sun, J. X. Wang et al., “Characterization of tibetan medicine zuota by multiple techniques,” Bioinorganic Chemistry and Applications, vol. 2013, Article ID 198545, 11 pages, 2013. View at Publisher · View at Google Scholar
  16. Men-Tsee-Khang (Tibetan Medical & Astro. Institute). Precious Pill: Rinchen Ratna Samphel, http://www.men-tsee-khang.org/medicine/rinchen-pills/ratna.htm.
  17. C. Commission, Pharmacopoeia of the People's Republic of China, China Medical Science Press, Beijing, China, 2015.
  18. W. B. Du, F. K. Huang, Y. D. Shaouo, L. F. Zhen, Y. L. Liu, and Y. Shang, “Progress in pharmacological and clinical research of Qishiwei Zhenzhu Wan,” Chinese Journal of Experimental Traditional Medical Formulae, vol. 6, article 107, 2013. View at Google Scholar
  19. L. Zhen, Y. Luo, F. Huang et al., “Neural protective effect of Rannasangpei on local cerebral ischemia in rats,” Pharmacology and Clinics of Chinese Materia Medica, vol. 30, no. 1, pp. 90–92, 2014. View at Google Scholar
  20. L. Zhen, Y. Luo, and F. Huang, “Effect of rannasangpei on the SOD, CAT and MDA in brain tissues of rats with local cerebral ischemia,” World Journal of Traditional Chinese Medicine, vol. 9, no. 3, pp. 347–354, 2014. View at Google Scholar
  21. Z. Bai, E. Jin, and X. Lu, “Effects of Tibetan Medicine Panansongpei on learning memory functions and superoxide dismutase and maleic dialdehyde in Alzheimer's disease model rats,” Journal of Qinghai Medical College, vol. 32, no. 1, pp. 29–31, 2011. View at Google Scholar
  22. Q. Zhu, D. Zhu, and G. Li, “Effect of Tibet-medicine Ratanasampil on serum β-amyloid protein and inflamatory cytokine levels in patients with Alzheimer's disease,” Chinese Journal of Geriatrics, vol. 30, no. 2, pp. 133–137, 2011. View at Google Scholar
  23. N. S. Jiwa, P. Garrard, and A. H. Hainsworth, “Experimental models of vascular dementia and vascular cognitive impairment: a systematic review,” Journal of Neurochemistry, vol. 115, no. 4, pp. 814–828, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Bachinskaya, R. Hoerr, and R. Ihl, “Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761®. Findings from a randomized controlled trial,” Neuropsychiatric Disease and Treatment, vol. 7, no. 1, pp. 209–215, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Gauthier and S. Schlaefke, “Efficacy and tolerability of Ginkgo biloba extract EGb 761(R) in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials,” Clinical Interventions in Aging, vol. 9, pp. 2065–2077, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Liu, J. Wu, J. Gu et al., “Baicalein improves cognitive deficits induced by chronic cerebral hypoperfusion in rats,” Pharmacology Biochemistry and Behavior, vol. 86, no. 3, pp. 423–430, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. R.-R. Zhao, F. Xu, X.-C. Xu et al., “Effects of alpha-lipoic acid on spatial learning and memory, oxidative stress, and central cholinergic system in a rat model of vascular dementia,” Neuroscience Letters, vol. 587, pp. 113–119, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. H.-J. Ji, J.-F. Hu, Y.-H. Wang, X.-Y. Chen, R. Zhou, and N.-H. Chen, “Osthole improves chronic cerebral hypoperfusion induced cognitive deficits and neuronal damage in hippocampus,” European Journal of Pharmacology, vol. 636, no. 1–3, pp. 96–101, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Peng, S. Xu, G. Chen, L. Wang, Y. Feng, and X. Wang, “l-3-n-Butylphthalide improves cognitive impairment induced by chronic cerebral hypoperfusion in rats,” Journal of Pharmacology and Experimental Therapeutics, vol. 321, no. 3, pp. 902–910, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. J. V. Alphen and A. Aris, Oriental Medicine: An Illustrated Guide to the Asian Arts of Healing, Serindia, 1995.
  32. B. X. Liao, A. Q. Zhu, and A. Q. Xi, “Effect of Ratnasampil on Alzheimer's disease patient's cognitive function and oxidative stress,” Chinese Journal of Gerontology, vol. 19, p. 11, 2009. View at Google Scholar
  33. A. Blokland, “Acetylcholine: a neurotransmitter for learning and memory?” Brain Research Reviews, vol. 21, no. 3, pp. 285–300, 1995. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Ishimaru, A. Takahashi, Y. Ikarashi, and Y. Maruyama, “Effect of transient cerebral ischaemia on acetylcholine release in the gerbil hippocampus,” NeuroReport, vol. 5, no. 5, pp. 601–604, 1994. View at Publisher · View at Google Scholar · View at Scopus
  35. R. A. Floyd and J. M. Carney, “Free radical damage to protein and DNA: mechanisms involved and relevant observations on brain undergoing oxidative stress,” Annals of Neurology, vol. 32, pp. S22–S27, 1992. View at Publisher · View at Google Scholar · View at Scopus
  36. B. A. Freeman and J. D. Crapo, “Biology of disease: free radicals and tissue injury,” Laboratory Investigation, vol. 47, no. 5, pp. 412–426, 1982. View at Google Scholar · View at Scopus
  37. B. K. Siesjö, C. D. Agardh, and F. Bengtsson, “Free radicals and brain damage,” Cerebrovascular and Brain Metabolism Reviews, vol. 1, no. 3, pp. 165–211, 1989. View at Google Scholar · View at Scopus
  38. S. Yoshida, S. Inoh, T. Asano et al., “Effect of transient ischemia on free fatty acids and phospholipids in the gerbil brain. Lipid peroxidation as a possible cause of postischemic injury,” Journal of Neurosurgery, vol. 53, no. 3, pp. 323–331, 1980. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Love, “Oxidative stress in brain ischemia,” Brain Pathology, vol. 9, no. 1, pp. 119–131, 1999. View at Google Scholar · View at Scopus
  40. P. H. Chan, “Role of oxidants in ischemic brain damage,” Stroke, vol. 27, no. 6, pp. 1124–1129, 1996. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Liu, M. Zhao, S. Yang, D.-R. Gong, D.-Z. Chen, and D.-Y. Du, “(2R,3S)-Pinobanksin-3-cinnamate improves cognition and reduces oxidative stress in rats with vascular dementia,” Journal of Natural Medicines, vol. 69, no. 3, pp. 358–365, 2015. View at Publisher · View at Google Scholar
  42. J. C. Reed, “Proapoptotic multidomain Bcl-2/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities,” Cell Death and Differentiation, vol. 13, no. 8, pp. 1378–1386, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. L. Wu, Q.-S. Zhao, T.-W. Li et al., “Yifei Xuanfei Jiangzhuo formula, a Chinese herbal decoction, improves memory impairment through inhibiting apoptosis and enhancing PKA/CREB signal transduction in rats with cerebral ischemia/reperfusion,” Molecular Medicine Reports, vol. 12, no. 3, pp. 4273–4283, 2015. View at Publisher · View at Google Scholar · View at Scopus